glp 1 and parkinson's GLP-1 Receptor Agonists for Disease: Promise or Mirage? GLP-1 does not slow Parkinson's

It showed a decreasing trend in the right basal ganglia, glutamineglutamate decreased in the right basal ganglia, and a decreasing trend in the left basal ganglia, and glutamate and GABA showed no changes

Utilizing Active Glow-Some technology, it improves the stability and absorption of glutathione, leaving the skin with a deep glow and suppleness

Eur Arch Psychiatry Clin Neurosci 249 : 174179

This was particularly evident in the mitochondrial proteins responsible for detoxifying H 2 S, and this downregulation was associated with a higher disease severity (70)

It could even mean buying out the patent for semaglutide from Novo Nordisk, or buying out the drug company altogether